Home
Learn More
Features & Pricing
Success Stories
Contact Us
Search Archives
PRWeb Direct
Submit Release
August 20, 2008
 
Industry Categories  
News by Country  
News by MSA  
Todays News  
Browse by Day  
PR Trackbacks™  
Featured Videos  
ViewNews™  
eBook Digests  
RSS  
PRWeb, a leader in online news and press release distribution, has been used by more than 40,000 organizations of all sizes to increase the visibility of their news, improve their search engine rankings and drive traffic to their Web site.
 
All Press Releases for October 31, 2004 Subscribe to this News Feed      
 

Celebrities Mislead & Confuse The Stem Cell Issue

Embryonic and adult stem cells. The media, celebs, and politics are misleading the public.

(PRWEB) October 31, 2004 -- Like Michael J Fox I am a young onset Parkinson's disease patient, one of thousands in the United States. However I do not have the star power to influence voters.

I was diagnosed four years ago at the age of 33 while serving in the US Air Force. The disease ended my marriage and my carreer but also gave me new direction in life. My days are like a roller coaster ride as medication swings me back and forth between "on" and "off" stages. I work full time now for the Department of Energy as a computer specialist, which is no easy task, but I fight my way through each and every day determined not to lose the battle.

With the pending election the topic of stem cells has found itself pushed into the spotlight. This is both good and bad. Good for the awareness and bad for the misleading statements, articles, and other media released on the subject. It is my hope that this article will help set the record straight.

There is no total restriction on stem cell research in the United States. The restrictions imposed are for "embryonic stem cell research" and the policy restricts utilizing federal funds (tax dollars) for embryonic stem cell research, it does not ban all stem cell research as the public is often lead to believe. Researchers in the United States are free to use pre-existing lines using federal money and new lines using private funding to pursue embryonic stem cell research. Embryonic stem cell research in fact is flourishing at Universities as well as through private grants across the United States. Not to mention the work being accomplished worldwide.
Adult stem cells have brought us treatments and cures for over 140 conditions. Embryonic stem cells have yielded none. The policy imposed by President Bush is a fair policy and it is working. Yes it was made using values and ethics, but those are two values that this country is supposed to represent.

Unfortunately celebrities fall prey to the pressures of politics. Displaying public support for a candidate, making unfair and unresearched statements about current stem cell policies, and creating misleading stem cell commercials is not the answer. We must educate the public on the issues and get away from the politics.

Embryonic stem cells
(source: NIH)
Embryonic stem cells, as their name suggests, are derived from embryos. Specifically, embryonic stem cells are derived from embryos that develop from eggs that have been fertilized in vitro—in an in vitro fertilization clinic—and then donated for research purposes with informed consent of the donors. They are not derived from eggs fertilized in a woman's body. The embryos from which human embryonic stem cells are derived are typically four or five days old and are a hollow microscopic ball of cells called the blastocyst.

Adult Stem Cells
(source: NIH)
An adult stem cell is an undifferentiated cell found among differentiated cells in a tissue or organ, can renew itself, and can differentiate to yield the major specialized cell types of the tissue or organ. The primary roles of adult stem cells in a living organism are to maintain and repair the tissue in which they are found. Some scientists now use the term somatic stem cell instead of adult stem cell. Unlike embryonic stem cells, which are defined by their origin (the inner cell mass of the blastocyst), the origin of adult stem cells in mature tissues is unknown.

While I am for embryonic stem cell research (excluding the fetal tissue stem cells they avoid talking about) I am very happy with the current policy. It would be morally wrong for our government to use tax payers money to do research on embryos from IVF clinics or other sources.

The study of embryonic stem cells is important.and should continue. We do not need to rely on federal funds. In 2003 an estimated $120 million of private funds was given to various researchers and universities to pursue embryonic research.

Researchers recently revealed research in which adult stem cells have been converted to long-lasting, dopamine-producing brain cells that could eventually be used to treat diseases such as Parkinson's. Dr Michel Levesque of Cedars Sinai has also shown the potential of adult stem cells for Parkinsons disease.

So What Is The Truth?
The report "Monitoring Stem Cell Research" by The President's Council on Bioethics released in January 2004 does a great job of separating the fact from fiction in regards to current policy regarding stem cell research in the United States. This report can be viewed in its entirety at: http://www.bioethics.gov/reports/stemcell/fulldoc.html

Here are a few of the facts that the report brings to light:
•This law effectively prohibits the use of federal funds to support any research that destroys human embryos or puts them at serious risk of destruction. It does not, however, prohibit the conduct of such research using private funding. Thus, it addresses itself not to what may or may not be lawfully done, but only to what may or may not be supported by taxpayer dollars. At the federal level, research that involves the destruction of embryos is neither prohibited nor supported and encouraged.
•Scientists may receive federal funding for using or deriving new animal embryonic stem cell lines, to assess the potential of these cells for treatment of animal models of human disease.
•Researchers can use federal funds for work involving human embryonic germ cells, obtained from aborted fetuses.
•Researchers can receive federal funds for work conducted on human adult (non-embryonic) stem cells.
•There are no restrictions regarding what American scientists can do with regard to adult stem cells using taxpayer funds, other than those requiring them to honor the usual human subject protections and clinical research requirements (if they are to be transplanted into human patients). The NIH has devoted substantial resources to the study of human adult stem cells, allocating over $170 million to the field in fiscal year 2002, and approximately $181.5 million in fiscal year 2003 (approximately ten times the amount devoted to human embryonic stem cell work).
•Researchers remain free to pursue work (including the derivation of new lines of embryonic stem cells) in the private sector, without government funding.
•Under present law, work supported by private funds can proceed without restriction.

Stem cells, embryonic or adult, can possibly one day cure Parkinson's and many other diseases. Being very much pro-embryonic stem cell research I can see both sides of the coin on this complex issue and am very comfortable with the decision made by President Bush.

Thomas N. Berdine
Albuquerque, NM
www.youngparkinsons.com

# # #

OPTIONS
Printer Friendly Version
Email this story to a colleague
CONTACT INFORMATION
Thomas Berdine
YoungParkinsons.com
505-293-5612
Email us Here
ATTACHED FILES

There are no multimedia files attached to this release. If this is your release, you may add images or other multimedia files through your login.

ABOUT PRESS RELEASES
If you have any questions regarding information in these press releases please contact the company listed in the press release. Please do not contact PRWeb. We will be unable to assist you with your inquiry. PRWeb disclaims any content contained in these releases. Our complete disclaimer appears here.
 
Disclaimer: If you have any questions regarding information in these press releases please contact the company listed in the press release.
Please do not contact PRWeb®. We will be unable to assist you with your inquiry.
PRWeb® disclaims any content contained in these releases. Our complete disclaimer appears here.

© Copyright 1997-2008, Vocus PRW Holdings, LLC.
Vocus, PRWeb and Publicity Wire are trademarks or registered trademarks of Vocus, Inc. or Vocus PRW Holdings, LLC.

Terms of Service | Privacy Policy | Copyright